OasisLMS

Overdose is a global public health challenge—but many overdose deaths are preventable.

This engaging session provides a global perspective on the evolving landscape of drug overdose, examining how changing drug markets, synthetic opioids, polysubstance use and emerging substances are reshaping overdose risks worldwide. The session will explore evidence-based strategies including naloxone, harm reduction, opioid agonist treatment, community-based prevention, early-warning systems and post-overdose care.

Particular emphasis will be placed on India and other low- and middle-income countries (LMICs), highlighting differences in drug-use patterns, gaps in overdose surveillance, access to naloxone and addiction treatment, and opportunities to strengthen community-based prevention.

Through international examples from the United States, Canada, Scotland and Portugal, the session will examine what has worked, what remains challenging, and what lessons can be adapted to local contexts.

The session will also explore the often-overlooked psychiatric dimension of overdose, including the intersection of substance use, mental illness, trauma and suicidality, and the importance of viewing every non-fatal overdose as an opportunity for treatment and recovery.

At the conclusion of this seminar, attendees should be able to:

• Understand the evolving global overdose landscape.
• Recognize key risk factors and clinical warning signs.
• Explore evidence-based overdose prevention and harm-reduction strategies.
• Understand the role of naloxone and opioid agonist treatment.
• Examine international approaches and lessons for India and LMICs.
• Consider future directions in overdose surveillance, technology and community prevention.
• Reframe overdose prevention around a simple goal: keeping people alive long enough to recover.

NO CME OFFERED

Johnson Pradeep MBBS, MD, MD (Psychiatry)   Dr. Johnson Pradeep is Professor and Head of the Department of Psychiatry at St. John’s Medical College & Hospital and Head of the Division of Mental Health & Neurosciences at St. John’s Research Institute. An accomplished psychiatrist, researcher, and educator, Dr. Pradeep’s work spans addiction psychiatry, community mental health, depression, tobacco cessation, and the integration of mental health services into primary care. He has served as principal investigator and collaborator on numerous national and international research initiatives and has published extensively in peer-reviewed journals. He is also actively involved in medical ethics and serves on the editorial team of the Journal of Addictive Diseases.

ACCREDITATION: 
In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION:
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.